Chi-Ching Chang

11PUBLICATIONS
12CO-AUTHORS
Molecular targetsOccupational epidemiologyStructural properties of condensed matterHaematological tumoursMechanobiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 01, 2026
Dipeptidyl peptidase-4 inhibitors are associated with a lower risk of osteoarthritis in patients with type 2 diabetes.

Yu-Hsiu Chen, Virginia Byers Kraus, Yu-Sheng Chang

|Jul 28, 2025
Severe cutaneous adverse reactions and risk of autoimmune disease, including psoriasis and inflammatory bowel disease: a cohort study.

Tzu-Min Lin, Yu-Sheng Chang, Yu-Chuan Shen

|Mar 10, 2022
Histone Deacetylase Inhibitors Downregulate Calcium Pyrophosphate Crystal Formation in Human Articular Chondrocytes.

Chi-Ching Chang, Kun-Lin Lee, Tze-Sian Chan

|Jan 19, 2022
H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection.

Yu-Chuan Shen, Hui-Ching Hsu, Tzu-Min Lin

|Aug 06, 2021
MCPIP1 Enhances TNF-α-Mediated Apoptosis through Downregulation of the NF-κB/cFLIP Axis.

Fat-Moon Suk, Chi-Ching Chang, Pei-Chi Sun

|Mar 01, 2021
Pneumocystis jirovecii pneumonia in autoimmune rheumatic diseases: a nationwide population-based study.

Hui-Ching Hsu, Yu-Sheng Chang, Tsung-Yun Hou

Pageof 2